SpecificationsOrganism/cell line/tissueHuman glioblastoma U87 MGSexMaleSequencer or array typeAffymetrix Human Gene Expression Array GPL15207Data formatRaw data (CEL files)Experimental factorsparental U87 cells, U87 tumor sphere cells treated with vehicle (DMSO) and U87 tumor sphere cells treated with ITEExperimental featuresIsolation and gene expression profiling of U87 cells grown in neural stem cell medium supplemented with ITEConsentN/ASample source locationHangzhou, China

1. Direct link to deposited data {#s0005}
================================

Deposited data can be found at: <http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE67986>

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Experimental design {#s0015}
------------------------

To determine the global transcriptional effects of ITE (Song et al. [@bb0015]) on parental and tumor sphere U87 cells, mRNA samples from three experimental groups (i.e., parental U87 cells, U87 tumor sphere cells treated with vehicle (DMSO) and U87 tumor sphere cells treated with ITE) were analyzed by Affymetrix Human Gene Expression Array.

2.2. Sample culture and isolation procedure {#s0020}
-------------------------------------------

For parental U87 sample, cells were cultured in DMEM (Invitrogen 21063-029, containing 16 mg/L [l]{.smallcaps}-tryptophan) supplemented with 10% fetal bovine serum (GIBCO 10099 or Pufei 1101-500). For tumor sphere assay (Ledur et al. [@bb0020]), U87 cells were plated at a density of 30,000 cells/ml with neural stem cell (NSC) medium which contains DMEM/F-12 (Corning R10-092-CV) supplemented with 1% (*v*/*v*) PS, 2% (*v*/*v*) B-27® Supplement Minus Vitamin A, 20 ng/mL EGF, 20 ng/mL bFGF and 10 ng/mL LIF to allow tumor sphere formation. U87 tumor sphere cells were cultured in NSC medium and treated with either 0.01% DMSO (vehicle) or 10 μM ITE for 5 days with the ITE being replenished every 12 h. After treatment, U87 tumor spheres were harvested and subjected to microarray analysis.

2.3. RNA isolation and microarray {#s0025}
---------------------------------

Briefly, RNA was extracted from U87 parental and tumor sphere cells by TRIzol method according to the manufacturer\'s instructions. Reverse transcription to the first-strand cDNA was primed with T7 oligo (dT) primer to synthesize cDNA containing a T7 promoter sequence. Second-strand cDNA synthesis converts the single-stranded cDNA into a double-stranded DNA (dsDNA) template for transcription. The reaction employs DNA polymerase and RNase H to simultaneously degrade the RNA and synthesize the second-strand cDNA. In vitro transcription to synthesize biotin-modified aRNA with IVT Labeling Master Mix generates multiple copies of biotin-modified aRNA from the double-stranded cDNA templates. aRNA purification removes unincorporated NTPs, salts, enzymes, and inorganic phosphate to improve the stability of the biotin-modified aRNA. Fragmentation of the labeled aRNA prepares the target for hybridization to GeneChip® 3′ expression arrays. Above procedures were carried out by GeneChip IVT express Kits (Affymetrix: 901229). The hybridization was carried out by GeneChip Hybridization, Wash, and Stain kit (affymetrix: 900720). The arrays were scanned at 570 nm with a confocal scanner from Affymetrix.

2.4. Quality control and data analysis {#s0030}
--------------------------------------

Analysis of the arrays was performed using the Partek GS 6.5. Normalization of the array was performed using a robust multiarray analysis (RMA). A p-value cut off of 0.05 was used to filter genes that were significantly expressed between the two samples. A fold change of 2 was used as a criterion for primary selection for differentially expressed genes. Boxplot and histograms of RMA processed probe intensities across all arrays shown in ([Fig. 1](#f0005){ref-type="fig"}A and B) indicated similar distribution of signal intensities between arrays. Principal component analysis (PCA, [Fig. 1](#f0005){ref-type="fig"}C) and hierarchical clustering (HC) by Pearson correlation distance and Ward\'s aggregation ([Fig. 1](#f0005){ref-type="fig"}D) were performed after selection of probes with a differential expression in any combination of array \> 1.5.
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